Avtor/Urednik		Homan, Griša; Oblak, Ciril
Naslov		Pomen PSA pri bolnikih z rakom na prostati
Prevedeni naslov		The role of PSA in prostatic carcinoma
Tip		članek
Vir		In: Tršinar B, editor. Rak na prostati. 1. slovenski urološki simpozij; 1995 maj 12-13; Ljubljana. Ljubljana: Lek, tovarna farmacevtskih in kemičnih izdelkov,
Leto izdaje		1995
Obseg		str. 1-4
Jezik		slo
Abstrakt		The development of prostatic carcinoma is not associated with characteristic early symptoms. Generally, the diagnosis is established late, or the condition is discovered accidentaly. Recently, determination of prostatic specific antigen (PSA) in the serum has been used for early diagnosis of prostatic carcinoma, in addition to standard rectal examination and transrectal ultrasound. PSA is synthetized exclusively in the prostatic parenchyma and is excreted in the seminal fluid. Thanks to its presence in the serum it is used as a reactive marker. Its serum levels, however, may be elevated in various other conditions. Its specificity rate is thus not ideal, and low PSA levels do not rule out cancer of the prostate. In combination with rectal examination and transrectal ultrasound, PSA determination is used as a useful marker for discovering and following adenocarcinoma of the prostate.
Deskriptorji		PROSTATIC NEOPLASMS PROSTATE-SPECIFIC ANTIGEN